Business Description

Description
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 12.37
Equity-to-Asset 0.83
Debt-to-Equity 0.07
Debt-to-EBITDA -0.07
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 51.45
9-Day RSI 58.48
14-Day RSI 60.94
6-1 Month Momentum % 170.79
12-1 Month Momentum % 259.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.98
Quick Ratio 7.98
Cash Ratio 6.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31.3
Shareholder Yield % 0.07

Financials (Next Earnings Date:2024-05-10 Est.)

BHVN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:BHVN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Biohaven Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -5.72
Beta 0
Volatility % 71.18
14-Day RSI 60.94
14-Day ATR ($) 3.470145
20-Day SMA ($) 53.02
12-1 Month Momentum % 259.48
52-Week Range ($) 12.35 - 62.21
Shares Outstanding (Mil) 81.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biohaven Ltd Filings

Filing Date Document Date Form
No Filing Data

Biohaven Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Biohaven Ltd Frequently Asked Questions

What is Biohaven Ltd(BHVN)'s stock price today?
The current price of BHVN is $56.74. The 52 week high of BHVN is $62.21 and 52 week low is $12.35.
When is next earnings date of Biohaven Ltd(BHVN)?
The next earnings date of Biohaven Ltd(BHVN) is 2024-05-10 Est..
Does Biohaven Ltd(BHVN) pay dividends? If so, how much?
Biohaven Ltd(BHVN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1